Stimulation of fibroblast proliferation

URGO is an international provider of healthcare solutions, offering a complete range of cost-effective wound management dressings – including the Urgotul, Urgocell and Urgosorb ranges.

 Other products available include the K range of compression/retention bandages, and the company’s anti-embolism hosiery – known as Preventex. URGOTUL and URGOCELL, based on Technology Lipido-Colloid (TLC), create a moist wound environment and are genuinely non-adherent – allowing painfree dressing changes. They are proven to increase stimulation of fibroblast proliferation by 45%, an essential factor in the wound healing process. TLC has now been combined with NOSF (Nano-OligoSaccharide Factor), an active compound designed to promote healing in all wounds at risk of delayed healing. Urgotul Start and Urgocell Start incorporate this technology. K Two is an innovative compression bandage system, spreading the pressure evenly between the two layers. Each bandage is printed with an etalonnage (pressure indicator) ensuring safe and accurate pressure on first application.

Latest Issues

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025